Safety and efficacy of biodegradable biliary and pancreatic stents

Not Applicable

Recruiting

• Conditions: Biliary anastomotic stricture; Hepatico-jejunal stricture; Post-ERCP pancreatitis; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12621001534875
• Lead Sponsor: Royal Prince Alfred Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-11-10
• Last Update Posted: 9 January 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Clinical criteria (1 required)
A. Patients with clinical indication for ERCP with a duct to duct anastomotic stricture or Hepaticojejunal stricture
Or
B. Those requiring pancreatic duct stent placement for post ERCP pancreatitis prophylaxis.

Other criteria:
Symptoms or signs: jaundice, cholangitis
Age 18 years old and above
Able to give informed consent

Exclusion Criteria

Contra-indication for endoscopy
Pregnancy
Patients who had undergone any treatment to the stricture in the last 6 months
Inability to pass a guidewire through stricture
Malignant stricture
Multiple concomitant bile duct strictures
Stricture length > 8cm
Anticoagulant therapy that cannot be discontinued prior to procedure

Study & Design

• Study Type: Interventional
• Study Design: Not specified